摘要
前列腺癌是全球性的公共健康挑战。前列腺癌特异性抗原（PSA）筛查能够有效提高前列腺癌检出率，显著降低晚期前列腺癌发生率及死亡率。然而，我国PSA筛查尚未普及，前列腺癌患者确诊时以晚期病例居多。因此，构建体检中心与泌尿外科前列腺癌早期筛查路径具有重要意义，以期早期发现，早期诊断以及早期治疗，达到降低前列腺癌死亡率的目的；为患者的长期随访提供了可靠的依据，有助于实现患者全方位健康管理；同时，建立以中国人群为基础的应用PSA进行前列腺癌筛查的相关研究大数据平台。
Prostatic cancer（PCa） is a global challenge to public health. Prostate-specific antigen （PSA） screening is able to effec- tively improve detection rate of PCa, and greatly reduce advance PCa incidence and death rate. However, PCa screening has not been polpularized in China, most PCa patients are confirmed in advanced cases. Therefore, it is important to set up physical examination cen- ter and early screen path in urinary surgery for PCa. It leads to detect, diagnose and treat PCa in early stage and reduce death rate ae- eordingly; it provides reliable basis for partients＇ long terra follow-up, contributes to realize patients＇ comprehensive hearth manage- ment; and it assists in setting up related study data base for PCa screening based on Chinese population.
出处
《检验医学》
CAS
2016年第B11期259-260,共2页
Laboratory Medicine
关键词
前列腺癌
前列腺癌特异性抗原
早期筛查
健康管理
Prostatic Cancer （PCa）
prostate-specific antigen （PSA）
early screening
health management
